Literature DB >> 758490

Toxicity of vidarabine.

S L Sacks, J L Smith, R B Pollard, V Sawhney, A S Mahol, P Gregory, T C Merigan, W S Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 758490     DOI： 10.1001/jama.1979.03290270020010

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humans.

Authors:  R J Whitley; B C Tucker; A W Kinkel; N H Barton; R F Pass; J D Whelchel; C G Cobbs; A G Diethelm; R A Buchanan
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

2.  Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.

Authors:  R F Schinazi; J Peters; C C Williams; D Chance; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

3.  Herpes simplex encephalitis: poor outcome despite adenine arabinoside therapy.

Authors:  W M Wenman; J L Brunton; B A Lank; A R Ronald
Journal:  Can Med Assoc J       Date:  1982-04-01       Impact factor: 8.262

4.  Neurotoxic effects during vidarabine therapy for herpes zoster.

Authors:  D R Burdge; A W Chow; S L Sacks
Journal:  Can Med Assoc J       Date:  1985-02-15       Impact factor: 8.262

5.  6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus.

Authors:  G W Koszalka; D R Averett; J A Fyfe; G B Roberts; T Spector; K Biron; T A Krenitsky
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

6.  Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination.

Authors:  S L Sacks; G H Scullard; R B Pollard; P B Gregory; W S Robinson; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

7.  Conjugates of adenine 9-alpha-D-arabinofuranoside monophosphate (ara-AMP) with lactosaminated homologous albumin are not immunogenic in the mouse.

Authors:  L Fiume; A Mattioli; C Busi; G Spinosa; T Wieland
Journal:  Experientia       Date:  1982-09-15

8.  Vidarabine encephalopathy.

Authors:  P A Cullis; R Cushing
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-12       Impact factor: 10.154

9.  Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver.

Authors:  L Fiume; A Mattioli; C Busi; C Accorsi
Journal:  Gut       Date:  1984-12       Impact factor: 23.059
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.